Share

    


In This Section

CLL Advisory Committees

ACCC would like to acknowledge our committee members for CLL projects.

Multidisciplinary CLL Care Advisory Committee

Kittai-Adam-100x100
Adam Kittai, MD
Clinical Assistant Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Dr. Kittai is a clinical assistant professor in the Division of Hematology at The Ohio State University in Columbus, Ohio. He is a clinical investigator with a focus on chronic lymphocytic leukemia and Richter’s Syndrome, specifically developing clinical trials for patients with these diseases. Dr. Kittai’s research focus is on bringing cellular therapies to patients with high-risk disease. Furthermore, Dr. Kittai is exploring what prognostic features of chronic lymphocytic leukemia are still relevant in the era of targeted therapies.

Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia Practice Advisory Committee

Kittai-Adam-100x100
Adam Kittai, MD
Clinical Assistant Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Dr. Kittai is a clinical assistant professor in the Division of Hematology at The Ohio State University in Columbus, Ohio. He is a clinical investigator with a focus on chronic lymphocytic leukemia and Richter’s Syndrome, specifically developing clinical trials for patients with these diseases. Dr. Kittai’s research focus is on bringing cellular therapies to patients with high-risk disease. Furthermore, Dr. Kittai is exploring what prognostic features of chronic lymphocytic leukemia are still relevant in the era of targeted therapies.

A Regional Approach to Advancing Care for Chronic Lymphocytic Leukemia Patients

Kittai-Adam-100x100
Adam Kittai, MD
Clinical Assistant Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Dr. Kittai is a clinical assistant professor in the Division of Hematology at The Ohio State University in Columbus, Ohio. He is a clinical investigator with a focus on chronic lymphocytic leukemia and Richter’s Syndrome, specifically developing clinical trials for patients with these diseases. Dr. Kittai’s research focus is on bringing cellular therapies to patients with high-risk disease. Furthermore, Dr. Kittai is exploring what prognostic features of chronic lymphocytic leukemia are still relevant in the era of targeted therapies.

Returning to Practice in the Post-COVID-19 Era: Resources for Treating Chronic Lymphocytic Leukemia

Kittai-Adam-100x100
Adam Kittai, MD
Clinical Assistant Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Dr. Kittai is a clinical assistant professor in the Division of Hematology at The Ohio State University in Columbus, Ohio. He is a clinical investigator with a focus on chronic lymphocytic leukemia and Richter’s Syndrome, specifically developing clinical trials for patients with these diseases. Dr. Kittai’s research focus is on bringing cellular therapies to patients with high-risk disease. Furthermore, Dr. Kittai is exploring what prognostic features of chronic lymphocytic leukemia are still relevant in the era of targeted therapies.